Find out how our first acquisition of Epinomics - Part of 10x Genomics furthers our leadership and broadens our IP portfolio in #SingleCellGenomics via Christina Farr CNBC cnb.cx/2Nx1uPG

Excited to be joining force with @10xgenomics to bring #epigenetics to boarder community to advance research and healthcare! @ChrissyFarr CNBC cnb.cx/2Nx1uPG

"10x Genomics, a Pleasanton, Calif.-based genomics platform that has raised over $280 million in VC funding, acquired Epinomics..." Axios' Dan Primack shares this week's major mergers & acquisitions, including 10x Genomics' acquisition of Epinomics - Part of 10x Genomics: axios.com/newsletters/ax…

.10x Genomics Acquires Epinomics - Part of 10x Genomics genomeweb.com/sequencing/10x…

The 10x Genomics acquisition of Epinomics - Part of 10x Genomics is "paving the way for a new understanding of disease, diagnostics and therapeutics" through single-cell sequencing and ATAC-seq technology. Via Allison Proffitt and Bio-IT World bio-itworld.com/2018/09/05/10x…

The leading company of the genomics field, 10x Genomics, just acquired Epinomics - Part of 10x Genomics, an epigenetic studies startup, to better understand illnesses, diagnostics, and therapies. bit.ly/2O9oCEx

Live webinar: Personal Regulome Navigation using Single Cell ATAC-Seq - Learn more about the new Chromium #SingleCell ATAC Solution, including a first look at customer data with Dr. Howard Chang, co-inventor of the #ATACSeq technology. #epigenetics bit.ly/2vjau3f

We are excited to announce the launch of the Chromium Single Cell ATAC Solution! The new solution enables researchers to reveal chromatin accessibility cell by cell with #singlecell #epigenomics #ATACseq. Learn more here: bit.ly/2OweHMq

Wow!!! 10x Genomics is honored to be recognized as the fastest growing private company in the Bay Area by the San Francisco Business Times #SFBTFast100

Excited to collaborate with @ParkerICI Stanford University to bring precision medicine to #cancer #immunotherapy. #SeanParker businesswire.com/news/home/2017…

Epinomics teams up with Parker’s I-O Institute for biomarker work Stanford Medicine FierceBiotech #immunotherapy bit.ly/2l0F6AQ

Excited to be viewed as frontier of #PersonalizedMedicine as GPS for medicine cnet.co/2msx4VA via CNET

At the intersection of "two of the hottest trends in biotech - cancer #immunotherapy & #epigenetics" @ClinicalOMICs clinicalomics.epubxp.com/i/798822-mar-a…

Thanks to team for another advancement of our technology for #cancer #immunotherapy #diagnostics and #epigenetics applications! GenomeWeb x.com/DailyNewsGW/st…

Honored by National Academy of Medicine National Academy of Medicine for electing our co-founder as new member!  ow.ly/s5gL30fSbTE

Congrats to our co-founder Howard Chang of Stanford Medicine for earning 2018 National Academy of Sciences Award in Molecular Biology! #MolecularBiology #epigenetics nasonline.org/programs/award…